Dr Kurtzberg said - doing stem cells multiple times using different donors causes antibodies to form which can cause future rejection of tissue transplants or autoimmune disease. As multiple donor cells contain multiple people dna which is foreign to the recipient. What does this doctor say about kutzburgs statement?
From her lectures and in what I've read from her so far, the level of antibodies that were found in the research patients who received allogeneic cells was increased but it was a clinically insignificant change.
@@AutismEssentialsIsrael thanks for your reply. I thought kutzburg was quite worried about this and said she would never treat her patients with multiple donor cells but only use a single donor for each individual patient. I'm confused on this matter
@@mimi2007-t4v I will quote from the transcript of a lecture she recently gave in November: "None of these children had any clinical sequelae to this effect, but it is something to be followed and could be of clinical interest in the future". She's not completely disregarding it, but doesn't seem so worried in my interpretation of her words.
That's a good question. There's a lot of factors that affect pricing: technological advancement, competition, but really make it affordable to the masses it needs to be covered by insurance. That will require governmental approval that this treatment is safe and effective for the condition you want to treat. That means more clinical research and lobbying.
Dr Kurtzberg said - doing stem cells multiple times using different donors causes antibodies to form which can cause future rejection of tissue transplants or autoimmune disease. As multiple donor cells contain multiple people dna which is foreign to the recipient. What does this doctor say about kutzburgs statement?
From her lectures and in what I've read from her so far, the level of antibodies that were found in the research patients who received allogeneic cells was increased but it was a clinically insignificant change.
@@AutismEssentialsIsrael thanks for your reply. I thought kutzburg was quite worried about this and said she would never treat her patients with multiple donor cells but only use a single donor for each individual patient. I'm confused on this matter
@@mimi2007-t4v I will quote from the transcript of a lecture she recently gave in November: "None of these children had any clinical sequelae to this effect, but it is something to be followed and could be of clinical interest in the future". She's not completely disregarding it, but doesn't seem so worried in my interpretation of her words.
When will you guys stop charging these astronomical prices?!
That's a good question. There's a lot of factors that affect pricing: technological advancement, competition, but really make it affordable to the masses it needs to be covered by insurance. That will require governmental approval that this treatment is safe and effective for the condition you want to treat. That means more clinical research and lobbying.